Sirona Biochem Corp. (SBM) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BioSyent, Inc.

Medexus Pharmaceuticals, Inc.

InnoCan Pharma Corp.

Theratechnologies, Inc.

Alpha Cognition, Inc.

Arch Biopartners, Inc.

Helix BioPharma Corp.

Satellos Bioscience, Inc.

Defence Therapeutics Inc

Mindset Pharma, Inc.

Sirona Biochem Corp.

Why is Sirona Biochem Corp. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-4.61%

EBIT Growth (5y)

5.79%

EBIT to Interest (avg)

-3.40

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.95

Sales to Capital Employed (avg)

0.27

Tax Ratio

10.40%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-4.57

EV to EBIT

-7.25

EV to EBITDA

-7.27

EV to Capital Employed

-19.10

EV to Sales

-19.10

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is not working for Sirona Biochem Corp.

Net Sales

At CAD 0.01 MM has Grown at -79.47%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CAD MM)

Interest

At CAD 0.22 MM has Grown at 175.29%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)

Net Profit

At CAD -0.89 MM has Fallen at -53.49%

over average net sales of the previous four periods of CAD -0.58 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CAD MM)

Pre-Tax Profit

At CAD -0.97 MM has Fallen at -47.99%

over average net sales of the previous four periods of CAD -0.65 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CAD MM)

Operating Cash Flow

Lowest at CAD -2.02 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Pre-Tax Profit

Lowest at CAD -0.97 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CAD MM)

Net Profit

Lowest at CAD -0.89 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (CAD MM)

EPS

Lowest at CAD -0

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (CAD)

Debtors Turnover Ratio

Lowest at -0.02%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 102.85% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales